放射治疗在八分生殖腺癌患者中的作用
Aneta Lebiedzińska1,2, Ewa Wasilewska-Teśluk1,2, Agnieszka Sopel1,2
1Department of Oncology, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Aleja Wojska Polskiego 37, 10-228 Olsztyn, Poland.
Cancers
|December 11, 2025
概括
放射治疗对于80岁及以上的患者来说是一个重要的癌症治疗方法,尽管数据有限,但仍然有好处. 像强度调节放射治疗 (IMRT) 和立体体辐射疗法 (SBRT) 这样的进步改善了这一群体的结果和耐受性.
科学领域:
- 老年瘤学 老年瘤学
- 辐射瘤学 辐射瘤学
- 临床试验 临床试验
背景情况:
- 对于接受放射治疗的80岁以上患者,有限的前性数据和试验代表性.
- 现有证据主要来自对小群体的回顾性分析.
- 放射治疗是癌症治愈和缓解癌症的基石.
研究的目的:
- 审查目前放射治疗在80岁及以上患者中的作用.
- 为突出这一人口群体需要基于证据的个性化瘤护理.
- 总结有关放射疗法的有效性,安全性和耐受性的知识.
主要方法:
- 对老年瘤患者 (80+) 放射治疗现有文献的综述.
- 分析技术进步,如强度调节放射疗法 (IMRT) 和立体性身体放射疗法 (SBRT).
- 讨论综合老年学评估 (CGA) 在治疗规划中的作用.
主要成果:
- 技术进步 (IMRT,SBRT) 提高了精度,并使低分化成为可能,使老年患者受益.
- 放射治疗通常在八十岁的人群中耐受良好,包括脆弱的个体.
- 低分离疗法可以减少治疗负担,同时保持疗效.
结论:
- 迫切需要进行前性研究,以指导80岁及以上患者使用放射治疗.
- 个性化瘤护理,通过综合老年医学评估,是必不可少的.
- 越来越多的老年人群需要针对这个年龄段的放射治疗量身定制的临床指南.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Biological Effects of Radiation
17.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.5K
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175


